Clinical outcomes associated with concomitant use of atazanavir and proton pump inhibitors

cited authors

  • Sahloff, Eric G; Duggan, Joan M

description

  • Pharmacokinetic studies have shown that the concomitant use of atazanavir and proton pump inhibitors (PPIs) decreases atazanavir plasma concentrations. Data describing clinical outcomes associated with this drug interaction are limited.

authors

publication date

  • 2006

published in

start page

  • 1731

end page

  • 6

volume

  • 40